Y-mAbs Therapeutics, Inc.
YMABDelisted Sep 16, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001722964
Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Y-mAbs Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 97 | 1 | 97 | +1 |
| Shares | 26.2M | 2.35K | 25.7M | −507.1K (−1.9%) |
| Value | $749.0M | $67.0K | $417.1M | −$331.8M (−44.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 250,000 | $4.05M | 0.42% |
| Renaissance Technologies LLC | 98,600 | $1.60M | 0.00% |
| Gsa Capital Partners LLP | 69,311 | $1.12M | 0.14% |
| Two Sigma Investments, LP | 38,792 | $629.0K | 0.00% |
| Ergoteles LLC | 18,566 | $301.0K | 0.01% |
| Walleye Capital LLC | 17,188 | $279.0K | 0.01% |
| Qube Research & Technologies Ltd | 15,577 | $253.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 15,063 | $244.0K | 0.00% |
| Millennium Management LLC | 12,613 | $204.0K | 0.00% |
| Advisor Group Holdings, Inc. | 4,159 | $67.0K | 0.00% |
| US Bancorp | 1,313 | $21.0K | 0.00% |
| Cassady Schiller Wealth Management, LLC | 525 | $9.00K | 0.01% |
| Signaturefd, LLC | 83 | $1.00K | 0.00% |
| Lindbrook Capital, LLC | 51 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 16 | $0 | 0.00% |
| Covestor Ltd | 16 | $0 | 0.00% |
Sold out (15)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| First Light Asset Management, LLC | 577,663 | $16.5M |
| Oracle Investment Management Inc | 315,642 | $9.01M |
| Brookfield Asset Management Inc. | 179,236 | $5.12M |
| Maven Securities LTD | 48,759 | $1.39M |
| Vident Investment Advisory, LLC | 38,835 | $1.11M |
| Skandinaviska Enskilda Banken AB (publ) | 37,900 | $1.08M |
| ExodusPoint Capital Management, LP | 17,399 | $497.0K |
| Principal Financial Group Inc | 15,971 | $455.0K |
| Cubist Systematic Strategies, LLC | 14,884 | $425.0K |
| Allstate Corp | 9,394 | $268.0K |
| Boothbay Fund Management, LLC | 7,682 | $219.0K |
| Arizona State Retirement System | 7,121 | $203.0K |
| Lazard Asset Management LLC | 1,801 | $51.0K |
| Penserra Capital Management LLC | 995 | $28.0K |
| Point72 Hong Kong Ltd | 995 | $28.0K |
Not filed for Q4 2021 yet (1)
Institutions that held Y-mAbs Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| First Mercantile Trust Co | 2,350 | $67.0K |